|
RAB8A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.895800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.058000E-02 |
| Normal-vs-Stage2 |
1.464330E-03 |
| Normal-vs-Stage3 |
5.838000E-03 |
| Normal-vs-Stage4 |
6.343800E-03 |
| Stage1-vs-Stage2 |
1.514190E-02 |
| Stage1-vs-Stage3 |
9.414300E-02 |
| Stage1-vs-Stage4 |
1.080820E-01 |
| Stage2-vs-Stage3 |
2.564800E-01 |
| Stage2-vs-Stage4 |
4.810400E-01 |
| Stage3-vs-Stage4 |
7.434400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.172400E-02 |
| Normal-vs-AfricanAmerican |
8.278200E-02 |
| Normal-vs-Asian |
1.962150E-01 |
| Caucasian-vs-AfricanAmerican |
7.989200E-01 |
| Caucasian-vs-Asian |
6.804800E-01 |
| AfricanAmerican-vs-Asian |
6.304600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.287920E-02 |
| Normal-vs-Female |
6.683000E-03 |
| Male-vs-Female |
9.222600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.021600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.601600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.980800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.114300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.863000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.814000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.739600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.492800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.297600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.309200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.424200E-01 |
| Classical-VS-Follicular |
1.91949999999164E-05 |
| Classical-VS-Other |
5.530800E-01 |
| Classical-VS-Normal |
1.124240E-01 |
| Tall-VS-Follicular |
1.206550E-01 |
| Tall-VS-Other |
9.325400E-01 |
| Tall-VS-Normal |
5.227900E-02 |
| Follicular-VS-Other |
4.309800E-01 |
| Follicular-VS-Normal |
3.61370000001582E-06 |
| Other-VS-Normal |
1.671240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.899900E-03 |
| Normal-vs-N1 |
2.904100E-02 |
| N0-vs-N1 |
8.890200E-01 |
|
|
